Mushrooms for Moms: From the Psychedelic Underground to the FDA for Postpartum Depression

Mar 12, 2024

11:30am – 12:30pm CT

Approximately 10-15% of new mothers suffer from post-partum depression every year, with limited treatment options available. Will the development of a novel drug inspired by the active compound in “magic mushrooms” provide a major breakthrough? Once a favorite of the legendary psychedelic chemist Sasha Shulgin, 4-OH-DiPT could provide much needed relief from post-partum depression. Today, biotech firms, women’s health advocates, and psychedelic VC investors are collaborating with the goal of taking a closely related yet novel psychedelic compound through clinical trials for FDA approval.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

photo of Maneesha Ghiya
Maneesha Ghiya

FemHealth Ventures

photo of Daniel Goldberg
Daniel Goldberg

Palo Santo Fund

photo of Greg Mayes
Greg Mayes

Reunion Neurosciences

photo of Melissa Whippo, LCSW
Melissa Whippo, LCSW

The Deva Collective